Tuesday 15th of March 2022 05:29:44 AM

AbbVie working with Scripps Research to develop COVID-19 antiviral treatments

Covid-19 pharmacy in capsule for emergency use, Health care medical and outbreak of virus concept I going to make a greatest artwork as I can, by my head, my hand and by my mind./iStock via Getty Images
  • AbbVie (NYSE:ABBV) will work with Scripps Research on the discovery of new antiviral treatments for COVID-19.
  • Scripps has been working on SARS-CoV-2 research through its drug development and discovery division, Calibr.
  • The companies say that the research will address gaps in patient needs for COVID treatments.
  • Read why Seeking Alpha contributor Cappuccino Finance argues that AbbVie (ABBV) is a hold.


Top gainers today
Top losers today